Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Other Operating Expenses (2019 - 2026)

Updated

Aligos Therapeutics' Other Operating Expenses came in at $18.89 million for Q3 2026, down 21.1% from $23.94 million a year earlier and down 21.4% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Other Operating Expenses (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Aligos Therapeutics reported Other Operating Expenses of $83.33 million, up 21.7% year-over-year; for FY2025, it was $69.45 million, down 1.2% from FY2024.

  • Other Operating Expenses has declined in each of the last four years, with a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
  • Going back by year, Other Operating Expenses was $70.27 million in FY2024 (-3.8%), $73.04 million in FY2023 (-14.1%), $85.08 million in FY2022 (-18.3%) and $104.15 million in FY2021 (+30.4%).
  • The five-year range for quarterly Other Operating Expenses is $13.98 million (Q2 2025) to $31.68 million (Q1 2022).
  • Year-over-year, Other Operating Expenses increased in four of the last eight quarters, with growth averaging 11.0%.
  • The fastest year-over-year change in Other Operating Expenses over five years came in Q2 2026 (growth of 72.1%), and the weakest in Q1 2023 (a decline of 42.7%).
  • Business Quant data shows ALGS's Other Operating Expenses at $24.05 million (Q2 2026), $23.35 million (Q1 2026) and $17.04 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 169,000.00
Jun 30, 2026 221,000.00
Mar 31, 2026 811,000.00
Dec 31, 2025 750,000.00
Sep 30, 2025 1.09 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 880,000.00
Dec 31, 2024 573,000.00
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 244,000.00
Sep 30, 2023 1.06 Mn
Jun 30, 2023 1.11 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 845,000.00
Sep 30, 2022 284,000.00
Jun 30, 2022 516,000.00
Mar 31, 2022 -5,000.00
Dec 31, 2021 176,000.00
API Access

Aligos Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY